« Fixed-Duration First-Line Therapy for Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) in Canada: A Canadian Expert Clinical Framework », Can Hematol Today, vol. 5, nᵒ s03, p. 2–16, nov. 2026, doi: 10.58931/cht.2026.5s0394.